These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 33314737)
1. Clinical and radiological predictors of epidermal growth factor receptor mutation in nonsmall cell lung cancer. Dang Y; Wang R; Qian K; Lu J; Zhang H; Zhang Y J Appl Clin Med Phys; 2021 Jan; 22(1):271-280. PubMed ID: 33314737 [TBL] [Abstract][Full Text] [Related]
2. A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma. Lu X; Li M; Zhang H; Hua S; Meng F; Yang H; Li X; Cao D Phys Med Biol; 2020 Mar; 65(5):055012. PubMed ID: 31978901 [TBL] [Abstract][Full Text] [Related]
3. Value of pre-therapy Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587 [TBL] [Abstract][Full Text] [Related]
4. Using contrast-enhanced CT and non-contrast-enhanced CT to predict EGFR mutation status in NSCLC patients-a radiomics nomogram analysis. Yang X; Liu M; Ren Y; Chen H; Yu P; Wang S; Zhang R; Dai H; Wang C Eur Radiol; 2022 Apr; 32(4):2693-2703. PubMed ID: 34807270 [TBL] [Abstract][Full Text] [Related]
5. Radiomics for the prediction of EGFR mutation subtypes in non-small cell lung cancer. Li S; Ding C; Zhang H; Song J; Wu L Med Phys; 2019 Oct; 46(10):4545-4552. PubMed ID: 31376283 [TBL] [Abstract][Full Text] [Related]
6. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms. Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618 [TBL] [Abstract][Full Text] [Related]
7. Genomics of non-small cell lung cancer (NSCLC): Association between CT-based imaging features and EGFR and K-RAS mutations in 122 patients-An external validation. Rizzo S; Raimondi S; de Jong EEC; van Elmpt W; De Piano F; Petrella F; Bagnardi V; Jochems A; Bellomi M; Dingemans AM; Lambin P Eur J Radiol; 2019 Jan; 110():148-155. PubMed ID: 30599853 [TBL] [Abstract][Full Text] [Related]
8. Assessing EGFR gene mutation status in non-small cell lung cancer with imaging features from PET/CT. Jiang M; Zhang Y; Xu J; Ji M; Guo Y; Guo Y; Xiao J; Yao X; Shi H; Zeng M Nucl Med Commun; 2019 Aug; 40(8):842-849. PubMed ID: 31290849 [TBL] [Abstract][Full Text] [Related]
9. CT-based non-invasive identification of the most common gene mutation status in patients with non-small cell lung cancer. Chen Z; Gao S; Ding C; Luo T; Xu J; Xu S; Li S Med Phys; 2024 Mar; 51(3):1872-1882. PubMed ID: 37706584 [TBL] [Abstract][Full Text] [Related]
10. Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status? Digumarthy SR; Padole AM; Gullo RL; Sequist LV; Kalra MK Medicine (Baltimore); 2019 Jan; 98(1):e13963. PubMed ID: 30608433 [TBL] [Abstract][Full Text] [Related]
11. Improved Prediction of Epidermal Growth Factor Receptor Status by Combined Radiomics of Primary Nonsmall-Cell Lung Cancer and Distant Metastasis. Hu Y; Geng Y; Wang H; Chen H; Wang Z; Fu L; Huang B; Jiang W J Comput Assist Tomogr; 2024 Sep-Oct 01; 48(5):780-788. PubMed ID: 38498926 [TBL] [Abstract][Full Text] [Related]
12. Impact of feature harmonization on radiogenomics analysis: Prediction of EGFR and KRAS mutations from non-small cell lung cancer PET/CT images. Shiri I; Amini M; Nazari M; Hajianfar G; Haddadi Avval A; Abdollahi H; Oveisi M; Arabi H; Rahmim A; Zaidi H Comput Biol Med; 2022 Mar; 142():105230. PubMed ID: 35051856 [TBL] [Abstract][Full Text] [Related]
13. Radiomics for Detection of the EGFR Mutation in Liver Metastatic NSCLC. Hou S; Fan Y; Wang X; Su J; Ren M; Wu Y; Zhou J; Qu M; Luo Y; Jiang W Acad Radiol; 2023 Jun; 30(6):1039-1046. PubMed ID: 35907759 [TBL] [Abstract][Full Text] [Related]
14. CT and clinical characteristics that predict risk of EGFR mutation in non-small cell lung cancer: a systematic review and meta-analysis. Zhang H; Cai W; Wang Y; Liao M; Tian S Int J Clin Oncol; 2019 Jun; 24(6):649-659. PubMed ID: 30835006 [TBL] [Abstract][Full Text] [Related]
15. Habitat radiomics and deep learning fusion nomogram to predict EGFR mutation status in stage I non-small cell lung cancer: a multicenter study. Wu J; Meng H; Zhou L; Wang M; Jin S; Ji H; Liu B; Jin P; Du C Sci Rep; 2024 Jul; 14(1):15877. PubMed ID: 38982267 [TBL] [Abstract][Full Text] [Related]
16. Quantitative Biomarkers for Prediction of Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer. Zhang L; Chen B; Liu X; Song J; Fang M; Hu C; Dong D; Li W; Tian J Transl Oncol; 2018 Feb; 11(1):94-101. PubMed ID: 29216508 [TBL] [Abstract][Full Text] [Related]
17. Radiomics of Spinal Metastases Originating From Primary Nonsmall Cell Lung Cancer or Breast Cancer and Ability to Predict Epidermal Growth Factor Receptor Mutation/Ki-67 Levels. Niu S; Zhang H; Wang X; Jiang W J Comput Assist Tomogr; 2023 Jul-Aug 01; 47(4):643-649. PubMed ID: 37380152 [TBL] [Abstract][Full Text] [Related]
18. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features. Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676 [TBL] [Abstract][Full Text] [Related]
19. Hybrid deep multi-task learning radiomics approach for predicting EGFR mutation status of non-small cell lung cancer in CT images. Gong J; Fu F; Ma X; Wang T; Ma X; You C; Zhang Y; Peng W; Chen H; Gu Y Phys Med Biol; 2023 Dec; 68(24):. PubMed ID: 37972417 [No Abstract] [Full Text] [Related]
20. Accurate prediction of epidermal growth factor receptor mutation status in early-stage lung adenocarcinoma, using radiomics and clinical features. Zhu H; Song Y; Huang Z; Zhang L; Chen Y; Tao G; She Y; Sun X; Yu H Asia Pac J Clin Oncol; 2022 Dec; 18(6):586-594. PubMed ID: 35098682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]